— Know what they know.
Not Investment Advice
Also trades as: 0R0G.L (LSE) · $vol 1M · KTF.DE (XETRA) · $vol 0M

MDLZ NASDAQ

Mondelez International, Inc.
1W: -2.6% 1M: +4.5% 3M: -4.1% YTD: +16.2% 1Y: +2.6% 3Y: +2.7% 5Y: +15.3%
$62.35
-0.62 (-0.98%)
 
Weekly Expected Move ±3.6%
$59 $62 $64 $66 $68
NASDAQ · Consumer Defensive · Food Confectioners · Tech Score Buy · Power 68 · $79.6B mcap · 1.27B float · 0.674% daily turnover · Short 37% of daily vol
Credit Risk of going bust: lower than 80% of companies Debt: 21.7% of company value Bonds: $315.7M held by 230 funds, 51 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.06 (down 98%), Mondelez International, Inc. would be worth roughly what it owes.
Total debt $22.06B against a stock market value of $79.58B.
Distance to default 9.63 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $13.22B (short-term plus half of long-term), stock volatility 23.7%; Altman Z 2.44. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.7 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 7.5%  ·  5Y Avg: 8.3%
Cost Advantage
47
Intangibles
21
Switching Cost
76
Network Effect
55
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MDLZ shows a Weak competitive edge (54.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 7.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$66
Low
$71
Avg Target
$74
High
Based on 7 analysts since Jul 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 32Hold: 8Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$70.86
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-26 RBC Capital Nik Modi $67 $66 -1 +3.4% $63.80
2026-10-21 BTIG Rob Dickerson $73 $74 +1 +15.6% $63.99
2026-07-30 Barclays — $68 $70 +2 +7.7% $64.99
2026-07-29 UBS Peter Grom $64 $68 +4 +3.8% $65.53
2026-07-29 Coker Palmer Thomas Palmer $69 $72 +3 +15.2% $62.48
2026-07-29 BTIG Rob Dickerson $70 $73 +3 +16.8% $62.48
2026-07-29 Jefferies Scott Marks $78 $73 -5 +16.8% $62.48
2026-04-29 Piper Sandler Michael Lavery $64 $65 +1 +5.7% $61.50
2026-04-29 Evercore ISI David Palmer $72 $71 -1 +15.5% $61.45
2026-04-29 UBS — $63 $64 +1 +9.3% $58.54
2026-04-29 Barclays Andrew Lazar $67 $68 +1 +16.2% $58.54
2026-04-13 BTIG Rob Dickerson Initiated $70 — +21.4% $57.68
2026-02-18 Bernstein — $84 $73 -11 +22.0% $59.86
2026-02-09 D.A. Davidson — $62 $64 +2 +7.5% $59.52
2026-02-04 D.A. Davidson Brian Holland $75 $62 -13 +4.7% $59.20
2026-02-04 Stifel Nicolaus — $70 $68 -2 +13.4% $59.94
2026-02-04 Morgan Stanley Megan Alexander Clapp $65 $66 +1 +11.0% $59.47
2026-02-04 Piper Sandler Michael Lavery $62 $64 +2 +7.6% $59.47
2026-02-04 Wells Fargo — $62 $65 +3 +9.3% $59.47
2026-02-04 UBS — $60 $63 +3 +5.9% $59.47
2026-01-28 Morgan Stanley — $68 $65 -3 +9.9% $59.15
2026-01-26 Deutsche Bank — $75 $61 -14 +4.5% $58.40
2026-01-21 Coker Palmer Thomas Palmer Initiated $69 — +20.3% $57.34
2026-01-14 UBS — $65 $60 -5 +5.6% $56.82
2026-01-08 Mizuho Securities — $70 $67 -3 +30.1% $51.51
2026-01-05 Wells Fargo Chris Carey $72 $62 -10 +16.4% $53.27
2025-11-21 Piper Sandler — $63 $62 -1 +11.2% $55.75
2025-10-30 Barclays — $77 $67 -10 +15.8% $57.85
2025-10-29 RBC Capital Nik Modi $83 $67 -16 +11.3% $60.21
2025-10-29 Stifel Nicolaus — $67 $70 +3 +19.1% $58.78
2025-10-29 Mizuho Securities — $73 $70 -3 +16.3% $60.21
2025-10-29 Bernstein Alexia Howard $88 $84 -4 +39.5% $60.21
2025-10-29 Morgan Stanley Megan Alexander Clapp $71 $68 -3 +17.5% $57.87
2025-10-29 Piper Sandler — $59 $63 +4 +4.6% $60.21
2025-10-29 Wells Fargo — $61 $72 +11 +19.6% $60.21
2025-10-28 Mizuho Securities — $75 $73 -2 +18.4% $61.65
2025-10-08 UBS Peter Grom $71 $65 -6 +3.8% $62.60
2025-10-06 Morgan Stanley — $69 $71 +2 +14.5% $61.99
2025-10-02 Berenberg Bank — Initiated $70 — +10.8% $63.17
2025-09-26 Evercore ISI — Initiated $72 — +15.1% $62.56
2025-07-31 Barclays — $72 $77 +5 +19.3% $64.56
2025-07-30 Bernstein — Initiated $88 — +35.2% $65.10
2025-03-27 Piper Sandler — $84 $59 -25 -12.6% $67.50
2025-03-24 Morgan Stanley — $75 $69 -6 +6.2% $64.95
2025-01-08 Wells Fargo Chris Carey $78 $61 -17 +4.6% $58.29
2024-10-30 Piper Sandler Michael Lavery $74 $84 +10 +22.9% $68.35
2024-10-30 Wells Fargo Chris Carey $77 $78 +1 +12.8% $69.15
2024-10-23 Piper Sandler Michael Lavery $76 $74 -2 +3.7% $71.35
2024-10-15 Bank of America Securities Peter Galbo $75 $84 +9 +19.1% $70.53
2024-08-09 Piper Sandler Michael Lavery $78 $76 -2 +9.9% $69.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
3
ROE
4
ROA
3
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MDLZ receives an overall rating of B. Strongest factors: ROE (4/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-12 B+ B
2026-10-01 B B+
2026-04-29 B- B
2026-04-28 B B-
2026-04-01 B- B
2026-03-02 B B-
2026-02-05 B- B
2026-02-04 B B-
2026-02-04 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 53 Grade A
Profitability
54
Balance Sheet
48
Earnings Quality
85
Growth
42
Value
54
Momentum
72
Safety
50
Cash Flow
52
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MDLZ scores highest in Earnings Quality (85/100) and lowest in Growth (42/100). An overall grade of A places MDLZ among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.37
Grey Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-2.61
Unlikely Manipulator
Ohlson O-Score
-7.71
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB
Score: 55.1/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.26x
Accruals: -1.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MDLZ scores 2.37, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MDLZ scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MDLZ's score of -2.61 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MDLZ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MDLZ receives an estimated rating of BBB (score: 55.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). MDLZ's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
22.84x
PEG
-31.40x
P/S
2.01x
P/B
3.02x
P/FCF
24.22x
P/OCF
16.85x
EV/EBITDA
15.39x
EV/Revenue
2.40x
EV/EBIT
19.84x
EV/FCF
30.82x
Earnings Yield
4.70%
FCF Yield
4.13%
Shareholder Yield
4.66%
Graham Number
$35.53
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 22.8x earnings, MDLZ commands a growth premium. Graham's intrinsic value formula yields $35.53 per share, 75% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.781
NI / EBT
×
Interest Burden
0.940
EBT / EBIT
×
EBIT Margin
0.121
EBIT / Rev
×
Asset Turnover
0.558
Rev / Assets
×
Equity Multiplier
2.693
Assets / Equity
=
ROE
13.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MDLZ's ROE of 13.3% is driven by Asset Turnover (0.558), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$23.13
Price/Value
2.50x
Margin of Safety
-150.05%
Premium
150.05%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with MDLZ's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. MDLZ trades at a 150% premium to its adjusted intrinsic value of $23.13, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 22.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$62.35
Median 1Y
$63.24
5th Pctile
$43.68
95th Pctile
$91.48
Ann. Volatility
22.1%
Analyst Target
$70.86
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Van de Put,
Dirk Chair & CEO
$1,624,615 $14,530,359 $24,516,114
Zaramella, Luca EVP,
COO & CFO
$1,174,690 $5,166,582 $9,662,771
Kuhn, Volker EVP
& President, Europe
$1,045,913 $4,114,098 $8,783,094
Valle, Gustavo EVP
& President, North America
$841,115 $3,419,603 $5,783,083
Renaud, Martin EVP
& Chief Marketing & Sales Officer
$774,846 $2,277,187 $4,654,167

CEO Pay Ratio

311:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $24,516,114
Avg Employee Cost (SGA/emp): $78,824
Employees: 91,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
91,000
+1.1% YoY
Revenue / Employee
$423,484
Rev: $38,537,000,000
Profit / Employee
$26,934
NI: $2,451,000,000
SGA / Employee
$78,824
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 16.3% 15.4% 15.2% 14.0% 11.5% 9.9% 14.0% 14.7% 16.6% 18.0% 15.1% 14.0% 13.5% 16.7% 13.3% 13.5% 13.1% 9.3% 10.1% 13.3% 13.31%
ROA 6.7% 6.4% 6.2% 5.8% 4.6% 3.9% 5.6% 6.0% 6.6% 7.0% 5.7% 5.4% 5.3% 6.6% 4.9% 5.1% 4.9% 3.5% 3.7% 4.9% 4.94%
ROIC 8.0% 8.2% 7.5% 7.9% 6.6% 5.5% 6.0% 6.8% 8.1% 9.0% 10.7% 9.5% 9.1% 11.0% 7.6% 8.0% 7.5% 5.9% 6.2% 7.5% 7.52%
ROCE 8.6% 8.9% 8.5% 8.7% 7.4% 6.7% 9.2% 9.9% 11.7% 12.3% 13.1% 12.9% 12.4% 13.8% 9.7% 9.1% 8.6% 7.1% 7.9% 9.6% 9.65%
Gross Margin 39.3% 37.0% 38.4% 36.3% 33.7% 35.4% 37.6% 39.4% 38.7% 37.3% 51.1% 33.5% 32.6% 38.6% 26.1% 32.7% 26.8% 28.2% 27.8% 42.6% 42.61%
Operating Margin 18.0% 15.7% 14.1% 12.7% 8.7% 9.6% 16.4% 16.8% 15.3% 12.8% 29.4% 10.2% 12.5% 16.8% 7.3% 13.0% 7.6% 9.3% 8.5% 20.8% 20.80%
Net Margin 17.5% 13.1% 11.0% 10.3% 6.9% 6.7% 22.7% 11.1% 10.9% 10.2% 15.2% 7.2% 9.3% 18.2% 4.3% 7.1% 7.6% 6.3% 5.6% 16.5% 16.55%
EBITDA Margin 22.4% 19.7% 17.1% 16.8% 13.2% 13.7% 29.2% 18.8% 19.6% 17.1% 33.6% 15.5% 17.3% 21.4% 10.8% 15.0% 12.3% 12.6% 12.6% 25.6% 25.58%
FCF Margin 12.3% 11.1% 11.8% 11.3% 9.8% 9.5% 8.9% 8.5% 9.8% 10.0% 10.3% 10.0% 10.2% 9.7% 9.1% 7.7% 6.1% 8.4% 6.6% 7.8% 7.78%
OCF Margin 15.4% 14.4% 14.9% 14.4% 12.9% 12.4% 11.9% 11.5% 12.8% 13.1% 13.6% 13.6% 13.9% 13.5% 12.8% 11.2% 9.5% 11.7% 9.9% 11.2% 11.18%
ROE 3Y Avg snapshot only 13.78%
ROE 5Y Avg snapshot only 13.97%
ROA 3Y Avg snapshot only 5.15%
ROIC 3Y Avg snapshot only 6.82%
ROIC Economic snapshot only 7.38%
Cash ROA snapshot only 6.23%
Cash ROIC snapshot only 9.44%
CROIC snapshot only 6.57%
NOPAT Margin snapshot only 8.91%
Pretax Margin snapshot only 11.35%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 19.29%
SBC / Revenue snapshot only 0.34%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 16.64 19.70 19.13 20.53 22.31 31.40 22.73 22.75 19.60 18.98 21.19 21.55 25.18 16.98 24.22 23.87 23.06 28.38 28.54 21.25 22.839
P/S Ratio 2.61 2.95 2.74 2.65 2.30 2.71 2.72 2.76 2.54 2.61 2.52 2.36 2.66 2.15 2.39 2.34 2.16 1.80 1.89 1.88 2.006
P/B Ratio 2.67 3.00 2.85 2.88 2.63 3.17 3.17 3.29 3.15 3.32 3.19 3.07 3.45 2.91 3.38 3.32 3.11 2.69 2.89 2.81 3.017
P/FCF 21.19 26.67 23.32 23.49 23.41 28.42 30.50 32.50 25.89 26.13 24.39 23.60 25.96 22.22 26.33 30.38 35.56 21.50 28.92 24.22 24.223
P/OCF 16.96 20.46 18.42 18.37 17.78 21.83 22.98 24.06 19.82 19.96 18.49 17.41 19.16 15.95 18.65 20.87 22.77 15.41 19.15 16.85 16.846
EV/EBITDA 16.04 17.30 17.34 17.14 17.72 22.45 18.04 17.62 15.03 14.68 13.49 13.34 15.11 11.81 17.77 17.81 18.21 18.44 18.43 15.39 15.386
EV/Revenue 3.21 3.52 3.37 3.25 2.95 3.40 3.36 3.35 3.08 3.12 3.02 2.89 3.18 2.62 2.90 2.88 2.71 2.33 2.41 2.40 2.396
EV/EBIT 20.06 21.36 21.52 21.26 22.59 29.25 22.15 21.42 17.98 17.46 15.91 15.91 18.18 14.08 22.77 22.88 23.92 25.57 25.19 19.84 19.844
EV/FCF 26.07 31.84 28.63 28.75 30.10 35.62 37.58 39.48 31.31 31.16 29.27 28.83 31.07 27.06 31.94 37.37 44.54 27.77 36.73 30.82 30.818
Earnings Yield 6.0% 5.1% 5.2% 4.9% 4.5% 3.2% 4.4% 4.4% 5.1% 5.3% 4.7% 4.6% 4.0% 5.9% 4.1% 4.2% 4.3% 3.5% 3.5% 4.7% 4.70%
FCF Yield 4.7% 3.7% 4.3% 4.3% 4.3% 3.5% 3.3% 3.1% 3.9% 3.8% 4.1% 4.2% 3.9% 4.5% 3.8% 3.3% 2.8% 4.7% 3.5% 4.1% 4.13%
EV/OCF snapshot only 21.432
EV/Gross Profit snapshot only 7.694
Acquirers Multiple snapshot only 20.992
Shareholder Yield snapshot only 4.66%
Graham Number snapshot only $35.53
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.73 0.74 0.68 0.68 0.69 0.60 0.68 0.65 0.61 0.62 0.77 0.68 0.63 0.68 0.61 0.64 0.61 0.59 0.54 0.60 0.599
Quick Ratio 0.53 0.54 0.48 0.45 0.46 0.40 0.49 0.43 0.41 0.43 0.63 0.50 0.42 0.48 0.40 0.39 0.37 0.39 0.37 0.40 0.395
Debt/Equity 0.74 0.71 0.72 0.72 0.83 0.88 0.80 0.76 0.72 0.70 0.69 0.73 0.73 0.68 0.78 0.82 0.84 0.87 0.84 0.83 0.828
Net Debt/Equity 0.62 0.58 0.65 0.65 0.75 0.80 0.74 0.71 0.66 0.64 0.64 0.68 0.68 0.63 0.72 0.76 0.79 0.78 0.78 0.76 0.764
Debt/Assets 0.30 0.30 0.30 0.30 0.33 0.33 0.31 0.30 0.29 0.28 0.25 0.28 0.28 0.27 0.29 0.30 0.31 0.31 0.30 0.31 0.310
Debt/EBITDA 3.60 3.42 3.56 3.48 4.37 4.94 3.71 3.34 2.82 2.61 2.42 2.60 2.68 2.28 3.39 3.58 3.92 4.60 4.21 3.57 3.570
Net Debt/EBITDA 3.00 2.81 3.22 3.14 3.94 4.54 3.40 3.12 2.60 2.37 2.25 2.42 2.48 2.11 3.12 3.33 3.67 4.16 3.92 3.29 3.292
Interest Coverage 12.08 12.97 12.78 12.79 10.37 8.54 10.17 9.78 10.70 11.69 13.21 12.96 12.68 13.32 8.89 8.59 9.76 7.57 7.90 10.24 10.237
Equity Multiplier 2.43 2.37 2.41 2.40 2.55 2.65 2.58 2.51 2.48 2.52 2.73 2.64 2.59 2.54 2.67 2.71 2.73 2.77 2.76 2.67 2.675
Cash Ratio snapshot only 0.079
Debt Service Coverage snapshot only 13.203
Cash to Debt snapshot only 0.078
FCF to Debt snapshot only 0.140
Defensive Interval snapshot only 313.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.42 0.43 0.44 0.45 0.45 0.46 0.47 0.49 0.51 0.51 0.48 0.50 0.51 0.52 0.50 0.51 0.52 0.55 0.56 0.56 0.558
Inventory Turnover 5.92 6.52 6.57 6.24 6.14 6.63 6.53 6.31 6.12 6.36 5.86 5.48 5.48 5.96 6.28 5.59 5.54 6.69 6.72 5.84 5.840
Receivables Turnover 10.98 12.40 10.45 12.73 11.09 11.61 10.21 12.64 11.21 10.72 9.64 11.80 9.91 9.71 8.77 11.09 9.42 9.91 9.02 10.53 10.527
Payables Turnover 2.83 2.70 2.64 2.83 2.94 2.82 2.79 2.98 3.06 2.80 2.55 2.66 2.64 2.50 2.65 2.73 2.71 2.82 2.85 2.82 2.818
DSO 33 29 35 29 33 31 36 29 33 34 38 31 37 38 42 33 39 37 40 35 34.7 days
DIO 62 56 56 59 59 55 56 58 60 57 62 67 67 61 58 65 66 55 54 63 62.5 days
DPO 129 135 138 129 124 129 131 122 119 130 143 137 138 146 138 134 135 129 128 130 129.5 days
Cash Conversion Cycle -34 -50 -48 -42 -32 -43 -39 -36 -27 -39 -43 -39 -35 -47 -38 -36 -30 -38 -33 -32 -32.3 days
Fixed Asset Turnover snapshot only 3.486
Operating Cycle snapshot only 97.2 days
Cash Velocity snapshot only 23.121
Capital Intensity snapshot only 1.796
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 8.3% 8.0% 7.9% 7.3% 7.4% 9.7% 12.5% 14.2% 16.2% 14.4% 9.9% 5.4% 2.1% 1.2% 0.9% 3.1% 4.1% 5.8% 7.8% 6.9% 6.93%
Net Income 42.5% 21.0% 11.0% -10.5% -29.6% -36.8% -6.0% 7.2% 46.4% 82.5% 8.8% -4.7% -16.9% -7.0% -16.1% -7.8% -7.5% -46.8% -27.5% -3.4% -3.43%
EPS 45.9% 23.9% 12.9% -8.7% -28.1% -35.4% -4.3% 8.5% 47.3% 84.0% 10.2% -3.0% -15.3% -5.4% -12.8% -4.3% -4.6% -44.9% -26.8% -2.9% -2.91%
FCF -0.9% 2.4% -7.7% 0.2% -14.5% -5.5% -14.6% -14.2% 16.3% 20.0% 26.9% 24.4% 6.4% -2.2% -11.1% -20.6% -38.1% -8.2% -22.3% 7.8% 7.83%
EBITDA 18.1% 18.8% 6.2% 2.1% -10.6% -18.5% 7.7% 14.7% 42.7% 60.5% 32.2% 19.9% 5.0% 5.6% -26.4% -22.9% -26.4% -39.6% -13.8% 2.9% 2.95%
Op. Income 27.4% 20.8% 4.3% 1.8% -15.1% -24.0% -11.6% -1.7% 31.7% 55.7% 70.4% 38.5% 15.2% 15.3% -36.1% -25.0% -29.0% -43.7% -12.6% -1.9% -1.88%
OCF Growth snapshot only 6.53%
Asset Growth snapshot only 0.32%
Equity Growth snapshot only 1.70%
Debt Growth snapshot only 2.58%
Shares Change snapshot only -0.54%
Dividend Growth snapshot only 5.09%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 2.8% 3.5% 4.4% 5.2% 5.8% 6.8% 8.1% 9.7% 10.6% 10.7% 10.1% 8.9% 8.4% 8.3% 7.6% 7.5% 7.3% 7.0% 6.1% 5.1% 5.15%
Revenue 5Y 1.4% 2.1% 2.5% 3.2% 3.5% 4.0% 4.6% 5.3% 6.3% 6.8% 7.0% 7.0% 7.0% 7.1% 7.0% 7.5% 7.5% 7.7% 7.7% 7.3% 7.34%
EPS 3Y 11.7% 10.0% 10.5% 2.8% -5.8% -9.5% 4.0% 8.2% 15.6% 13.7% 6.0% -1.3% -3.5% 4.0% -2.7% 0.3% 6.0% -1.3% -11.1% -3.4% -3.38%
EPS 5Y 42.9% 23.5% 21.8% 19.3% 9.5% 0.5% 5.4% 7.4% 8.1% 9.6% 7.3% 2.7% 0.9% 5.3% 1.6% 3.3% 4.6% -5.1% -5.3% -2.2% -2.23%
Net Income 3Y 9.8% 8.3% 8.9% 1.1% -7.5% -11.1% 2.2% 6.5% 13.7% 11.7% 4.3% -2.9% -5.0% 2.4% -5.0% -2.0% 4.0% -3.4% -12.9% -5.3% -5.30%
Net Income 5Y 39.7% 21.0% 19.3% 16.9% 7.3% -1.4% 3.5% 5.6% 6.4% 8.0% 5.7% 1.1% -0.8% 3.6% -0.5% 1.2% 2.5% -7.2% -7.1% -4.0% -4.01%
EBITDA 3Y 11.9% 12.4% 12.4% 6.0% 1.7% -1.5% 9.3% 13.8% 14.6% 15.8% 14.8% 12.0% 10.2% 11.3% 1.6% 2.0% 3.3% 0.8% -5.7% -1.6% -1.64%
EBITDA 5Y 21.3% 15.9% 13.7% 13.7% 7.4% 1.9% 5.1% 7.5% 12.3% 13.2% 15.1% 10.3% 9.5% 10.1% 4.9% 6.4% 3.1% -0.2% -0.8% 2.2% 2.18%
Gross Profit 3Y 2.6% 2.8% 3.7% 4.0% 3.0% 3.1% 4.9% 7.5% 9.0% 9.6% 11.2% 8.8% 7.5% 8.2% 1.9% 2.3% 1.8% -1.1% -1.3% -0.4% -0.35%
Gross Profit 5Y 1.7% 2.1% 2.2% 2.6% 2.1% 2.4% 2.6% 3.3% 5.0% 5.9% 8.3% 7.7% 6.7% 6.6% 3.2% 3.7% 2.5% 0.9% 0.6% 1.9% 1.87%
Op. Income 3Y 11.8% -17.2% -17.7% -19.2% -23.4% -2.8% 2.5% 9.9% 12.5% 12.6% 16.3% 11.5% 8.8% 10.9% -1.3% 0.7% 2.5% 0.4% -1.6% 0.6% 0.64%
Op. Income 5Y 25.0% 12.6% 10.8% 11.1% 37.4% 25.5% 20.8% 26.4% 9.4% -7.7% -3.4% -6.4% -7.4% 10.5% 3.2% 6.6% 3.1% -1.5% -2.6% 0.4% 0.40%
FCF 3Y 10.7% 3.6% 5.5% 6.6% 0.2% -0.4% 0.3% -6.7% -0.5% 5.1% -0.0% 2.3% 1.9% 3.5% -1.3% -5.4% -8.5% 2.5% -4.3% 2.1% 2.11%
FCF 5Y 9.6% 14.5% 17.4% 15.3% 15.4% 13.7% 2.8% 3.4% 6.2% 4.8% 4.9% 5.3% 4.5% 3.0% 2.6% -4.3% -8.3% 0.8% -7.1% -1.8% -1.75%
OCF 3Y 5.9% 1.6% 2.8% 4.2% -0.1% -0.5% 1.0% -4.4% 1.1% 5.9% 2.3% 5.2% 4.7% 5.8% 2.4% -1.2% -3.2% 4.9% -0.1% 4.3% 4.26%
OCF 5Y 4.8% 7.8% 9.8% 9.3% 9.5% 8.6% 1.9% 2.2% 4.3% 3.6% 4.2% 5.1% 4.9% 4.4% 4.3% -1.4% -4.1% 2.6% -3.3% 1.1% 1.11%
Assets 3Y 1.7% 2.3% 2.0% 1.3% 2.1% 3.3% 4.6% 3.9% 2.3% 1.7% 5.4% 3.2% 2.4% 0.7% 0.5% 2.5% 1.6% 0.2% -0.8% -0.4% -0.36%
Assets 5Y 1.2% 1.7% 1.8% 1.0% 1.5% 2.5% 2.4% 2.7% 2.1% 2.6% 3.9% 2.8% 2.5% 1.2% 1.6% 2.0% 1.5% 1.1% 1.4% 1.4% 1.40%
Equity 3Y 2.9% 3.3% 2.9% 1.8% -0.2% -0.4% 3.2% 3.3% 1.9% 0.9% 1.7% 0.2% 0.2% -1.6% -2.9% -1.6% -0.6% -1.3% -3.0% -2.4% -2.39%
Book Value 3Y 4.6% 4.9% 4.4% 3.4% 1.7% 1.4% 5.0% 4.9% 3.7% 2.7% 3.4% 1.8% 1.8% -0.0% -0.6% 0.6% 1.3% 0.8% -1.0% -0.4% -0.42%
Dividend 3Y 4.7% 4.4% 4.2% 4.5% 4.8% 4.7% 4.5% 4.3% 4.5% 4.7% 4.6% 4.7% 4.6% 4.5% 5.1% 4.8% 4.3% 4.1% 3.6% 3.5% 3.54%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.23 0.55 0.64 0.72 0.73 0.73 0.71 0.73 0.77 0.83 0.90 0.93 0.93 0.94 0.96 0.97 0.95 0.96 0.97 0.97 0.971
Earnings Stability 0.77 0.82 0.78 0.69 0.24 0.02 0.79 0.59 0.16 0.13 0.82 0.22 0.04 0.18 0.03 0.00 0.02 0.01 0.41 0.75 0.751
Margin Stability 0.99 0.99 0.98 0.98 0.96 0.96 0.95 0.96 0.96 0.96 0.94 0.96 0.96 0.96 0.91 0.92 0.91 0.87 0.85 0.88 0.881
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.83 0.92 0.96 0.96 0.88 0.85 0.98 0.97 0.81 0.50 0.96 0.98 0.93 0.97 0.94 0.97 0.97 0.81 0.89 0.99 0.986
Earnings Smoothness 0.65 0.81 0.90 0.89 0.65 0.55 0.94 0.93 0.62 0.42 0.92 0.95 0.82 0.93 0.83 0.92 0.92 0.39 0.68 0.97 0.965
ROE Trend 0.03 0.02 0.01 -0.00 -0.02 -0.04 -0.00 -0.00 0.02 0.05 0.01 0.00 -0.00 0.03 -0.01 -0.00 -0.01 -0.08 -0.04 -0.01 -0.009
Gross Margin Trend 0.00 -0.00 -0.01 -0.02 -0.03 -0.03 -0.04 -0.03 -0.00 0.01 0.05 0.03 0.02 0.02 -0.06 -0.06 -0.07 -0.10 -0.08 -0.05 -0.053
FCF Margin Trend -0.00 -0.01 -0.01 -0.02 -0.03 -0.02 -0.04 -0.03 -0.01 -0.00 -0.00 0.00 0.00 -0.00 -0.01 -0.02 -0.04 -0.01 -0.03 -0.01 -0.011
Sustainable Growth Rate 9.8% 8.9% 8.4% 7.1% 4.4% 2.7% 6.8% 7.4% 9.0% 10.1% 7.3% 6.0% 5.4% 8.2% 4.4% 4.5% 3.9% -0.1% 0.4% 3.7% 3.69%
Internal Growth Rate 4.2% 3.8% 3.6% 3.0% 1.8% 1.1% 2.8% 3.1% 3.7% 4.1% 2.8% 2.4% 2.2% 3.3% 1.7% 1.7% 1.5% — 0.1% 1.4% 1.39%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.98 0.96 1.04 1.12 1.26 1.44 0.99 0.95 0.99 0.95 1.15 1.24 1.31 1.06 1.30 1.14 1.01 1.84 1.49 1.26 1.262
FCF/OCF 0.80 0.77 0.79 0.78 0.76 0.77 0.75 0.74 0.77 0.76 0.76 0.74 0.74 0.72 0.71 0.69 0.64 0.72 0.66 0.70 0.695
FCF/Net Income snapshot only 0.877
OCF/EBITDA snapshot only 0.718
CapEx/Revenue 3.1% 3.4% 3.1% 3.1% 3.1% 2.9% 2.9% 3.0% 3.0% 3.1% 3.3% 3.6% 3.6% 3.8% 3.7% 3.5% 3.4% 3.3% 3.3% 3.4% 3.41%
CapEx/Depreciation snapshot only 0.973
Accruals Ratio 0.00 0.00 -0.00 -0.01 -0.01 -0.02 0.00 0.00 0.00 0.00 -0.01 -0.01 -0.02 -0.00 -0.01 -0.01 -0.00 -0.03 -0.02 -0.01 -0.013
Sloan Accruals snapshot only -0.041
Cash Flow Adequacy snapshot only 1.140
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.4% 2.2% 2.3% 2.4% 2.8% 2.3% 2.3% 2.2% 2.3% 2.3% 2.4% 2.7% 2.4% 3.0% 2.7% 2.8% 3.0% 3.6% 3.4% 3.4% 3.24%
Dividend/Share $1.27 $1.30 $1.33 $1.37 $1.41 $1.44 $1.47 $1.50 $1.54 $1.58 $1.63 $1.67 $1.71 $1.75 $1.83 $1.87 $1.89 $1.92 $1.94 $1.97 $2.02
Payout Ratio 40.2% 42.5% 44.4% 49.4% 62.0% 73.1% 51.3% 49.8% 45.9% 43.6% 51.5% 57.2% 60.3% 50.9% 66.5% 66.8% 69.9% 1.0% 96.1% 72.3% 72.27%
FCF Payout Ratio 51.1% 57.5% 54.2% 56.5% 65.1% 66.1% 68.9% 71.2% 60.7% 60.0% 59.3% 62.6% 62.2% 66.7% 72.3% 85.0% 1.1% 76.9% 97.4% 82.4% 82.37%
Total Payout Ratio 96.2% 91.5% 87.7% 1.0% 1.3% 1.5% 93.5% 76.6% 64.2% 74.8% 91.5% 1.1% 1.1% 1.0% 1.6% 1.5% 1.6% 2.0% 1.3% 99.1% 99.12%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.12 0.11 0.11 0.11 0.12 0.11 0.11 0.10 0.11 0.11 0.12 0.12 0.11 0.12 0.11 0.11 0.10 0.09 0.08 0.08 0.079
Buyback Yield 3.4% 2.5% 2.3% 2.7% 3.0% 2.4% 1.9% 1.2% 0.9% 1.6% 1.9% 2.4% 2.2% 3.0% 3.8% 3.4% 3.7% 3.4% 1.2% 1.3% 1.26%
Net Buyback Yield 3.4% 2.5% 2.3% 2.7% 3.0% 2.4% 1.9% 1.2% 0.9% 1.6% 1.9% 2.4% 2.2% 3.0% 3.8% 3.4% 3.7% 3.4% 1.2% 1.3% 1.26%
Total Shareholder Return 5.8% 4.6% 4.6% 5.1% 5.8% 4.7% 4.1% 3.4% 3.3% 3.9% 4.3% 5.0% 4.6% 6.0% 6.5% 6.1% 6.8% 7.0% 4.5% 4.7% 4.66%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.77 0.78 0.78 0.79 0.79 0.76 0.75 0.75 0.75 0.76 0.74 0.72 0.72 0.76 0.78 0.79 0.82 0.75 0.75 0.78 0.781
Interest Burden (EBT/EBIT) 1.27 1.16 1.18 1.07 1.00 0.98 1.06 1.03 1.02 1.01 0.85 0.84 0.84 0.90 0.99 0.98 1.00 0.92 0.93 0.94 0.940
EBIT Margin 0.16 0.16 0.16 0.15 0.13 0.12 0.15 0.16 0.17 0.18 0.19 0.18 0.17 0.19 0.13 0.13 0.11 0.09 0.10 0.12 0.121
Asset Turnover 0.42 0.43 0.44 0.45 0.45 0.46 0.47 0.49 0.51 0.51 0.48 0.50 0.51 0.52 0.50 0.51 0.52 0.55 0.56 0.56 0.558
Equity Multiplier 2.44 2.42 2.43 2.41 2.49 2.51 2.50 2.46 2.52 2.58 2.65 2.58 2.54 2.53 2.70 2.67 2.66 2.65 2.72 2.69 2.693
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $3.16 $3.06 $3.00 $2.78 $2.27 $1.98 $2.87 $3.02 $3.35 $3.64 $3.17 $2.93 $2.84 $3.44 $2.76 $2.80 $2.71 $1.90 $2.02 $2.72 $2.72
Book Value/Share $19.67 $20.12 $20.14 $19.81 $19.32 $19.55 $20.56 $20.88 $20.83 $20.77 $21.02 $20.54 $20.72 $20.10 $19.76 $20.16 $20.08 $20.00 $19.93 $20.62 $20.71
Tangible Book/Share $-9.05 $-8.54 $-9.50 $-9.31 $-10.92 $-11.84 $-11.06 $-10.83 $-10.40 $-11.29 $-10.83 $-11.20 $-11.44 $-11.14 $-12.86 $-13.76 $-13.57 $-14.03 $-13.94 $-13.20 $-13.20
Revenue/Share $20.14 $20.44 $20.92 $21.51 $22.09 $22.91 $23.96 $24.88 $25.84 $26.40 $26.67 $26.69 $26.90 $27.19 $27.94 $28.56 $28.88 $29.83 $30.42 $30.71 $30.78
FCF/Share $2.48 $2.26 $2.46 $2.43 $2.17 $2.18 $2.14 $2.11 $2.54 $2.64 $2.75 $2.67 $2.75 $2.63 $2.54 $2.20 $1.76 $2.50 $1.99 $2.39 $2.39
OCF/Share $3.10 $2.95 $3.12 $3.11 $2.85 $2.84 $2.84 $2.85 $3.32 $3.46 $3.63 $3.63 $3.73 $3.66 $3.58 $3.21 $2.74 $3.49 $3.01 $3.43 $3.44
Cash/Share $2.42 $2.52 $1.39 $1.39 $1.58 $1.40 $1.40 $1.08 $1.18 $1.33 $1.02 $1.04 $1.13 $1.01 $1.20 $1.16 $1.05 $1.64 $1.18 $1.33 $1.33
EBITDA/Share $4.04 $4.16 $4.06 $4.08 $3.68 $3.46 $4.46 $4.73 $5.29 $5.60 $5.97 $5.78 $5.66 $6.02 $4.56 $4.62 $4.30 $3.77 $3.97 $4.78 $4.78
Debt/Share $14.53 $14.21 $14.46 $14.18 $16.09 $17.12 $16.54 $15.83 $14.93 $14.62 $14.44 $15.02 $15.20 $13.71 $15.44 $16.56 $16.83 $17.34 $16.74 $17.07 $17.07
Net Debt/Share $12.12 $11.69 $13.07 $12.80 $14.51 $15.72 $15.14 $14.75 $13.75 $13.30 $13.43 $13.98 $14.07 $12.70 $14.25 $15.40 $15.78 $15.70 $15.56 $15.75 $15.75
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.371
Altman Z-Prime snapshot only 3.120
Piotroski F-Score 6 7 8 6 5 5 5 6 7 8 9 7 7 8 5 5 5 5 6 6 6
Beneish M-Score -2.34 -2.37 -2.35 -2.38 -2.43 -2.33 -2.29 -2.31 -2.33 -2.37 -2.58 -2.42 -2.35 -2.47 -1.95 -2.34 -2.28 -2.37 -2.57 -2.61 -2.613
Ohlson O-Score snapshot only -7.710
Net-Net WC snapshot only $-24.47
EVA snapshot only $-1164695115.45
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 55.81 60.63 55.17 59.36 52.87 50.68 55.24 57.23 59.72 59.63 58.90 55.70 60.70 61.01 56.97 52.98 51.97 51.43 50.51 55.08 55.081
Credit Grade snapshot only 9
Credit Trend snapshot only 2.102
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 52
Sector Credit Rank snapshot only 42

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms